Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) EBT (2018 - 2025)

Dna X (SONM) has disclosed EBT for 8 consecutive years, with -$4.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 94.7% year-over-year to -$4.7 million, compared with a TTM value of -$33.7 million through Sep 2025, down 159.02%, and an annual FY2024 reading of -$34.1 million, down 12092.25% over the prior year.
  • EBT was -$4.7 million for Q3 2025 at Dna X, up from -$7.3 million in the prior quarter.
  • Across five years, EBT topped out at $12.8 million in Q4 2022 and bottomed at -$22.3 million in Q4 2024.
  • Average EBT over 5 years is -$4.4 million, with a median of -$4.2 million recorded in 2022.
  • The sharpest move saw EBT skyrocketed 208.86% in 2022, then crashed 1670.08% in 2024.
  • Year by year, EBT stood at -$11.8 million in 2021, then surged by 208.86% to $12.8 million in 2022, then plummeted by 109.82% to -$1.3 million in 2023, then plummeted by 1670.08% to -$22.3 million in 2024, then soared by 79.09% to -$4.7 million in 2025.
  • Business Quant data shows EBT for SONM at -$4.7 million in Q3 2025, -$7.3 million in Q2 2025, and $590000.0 in Q1 2025.